Histone monoaminylation dynamics are regulated by a single enzyme and promote neural rhythmicity

Qingfei Zheng, Ryan M. Bastle, Shuai Zhao, Lingchun Kong, Lauren E. Vostal, Aarthi Ramakrishnan, Li Shen, Sasha L. Fulton, Haifeng Wang, Baichao Zhang, Akhil Upad, Lauren Dierdorff, Robert E. Thompson, Henrik Molina, Stephanie Stransky, Simone Sidoli, Tom W. Muir, Haitao Li, Yael David, Ian MazebioRxiv 2022 · DOI

TL;DR

This paper reveals that the enzyme TGM2 acts as a master regulator of histone monoaminylation, not only adding these modifications but also removing and switching them. This dynamic control, influenced by local monoamine levels, is crucial for neural rhythmicity, with a newly identified modification, H3Q5his, playing a key role in regulating gene expression and behavior.

What Problem Does This Paper Address?

Histone modifications are fundamental to gene regulation, and while many well-studied modifications like methylation and acetylation are understood to be dynamically regulated by "writer," "eraser," and "reader" proteins, the precise mechanisms governing less common modifications, particularly those involving monoamine neurotransmitters, remained unclear. Specifically, how these "monoaminylation" marks on histones are added, removed, and potentially interconverted to allow for neuronal plasticity was a significant knowledge gap. This paper addresses this by investigating the role of TGM2 in the dynamic regulation of histone monoaminylation, including the discovery and characterization of a new form: H3Q5 histaminylation.

Methods

The researchers employed a multi-pronged approach:

  • In vitro biochemical assays: They used purified recombinant TGM2 (wild-type and a catalytically dead mutant) and synthesized histone peptides to study the enzyme's activity in controlled conditions. Techniques like LC-MS/MS and MALDI-TOF mass spectrometry were used to identify and quantify modified peptides.
  • Cell-based assays: They used HEK293T and HeLa cells, some engineered to express TGM2, to study monoaminylation dynamics in a cellular context. This involved pulse-chase experiments to track the stability of modifications and western blotting to detect specific modifications.
  • In vivo studies in mice: They investigated the role of H3Q5his in the brain, specifically in the tuberomammillary nucleus (TMN), a region rich in histaminergic neurons. This included RNA-seq to analyze gene expression patterns, western blotting to assess histone modification levels, and behavioral assays (locomotor activity) to link molecular changes to physiological outcomes.
  • Structural modeling and biophysical techniques: To understand the molecular basis of TGM2's interactions, they used X-ray crystallography and isothermal titration calorimetry (ITC) to study the binding of modified histones to key protein partners.
  • Antibody generation and validation: A new site-specific antibody for H3Q5his was developed and rigorously validated for its specificity.

Datasets

  • RNA-seq data: Collected from mouse TMN tissues at various time points across the 24-hour cycle.
  • Mass spectrometry data: Generated from in vitro biochemical assays and cell-based experiments to identify and quantify histone modifications.
  • X-ray crystallography data: Used to determine the structure of protein complexes.

Key Insights and Ideas

  • TGM2 as a "Swiss Army knife" for histone monoaminylation: The most striking insight is TGM2's multifaceted role – it's not just a "writer" (adding modifications) but also an "eraser" (removing them) and a "re-writer" (switching between different monoamine modifications). This dynamic capability is crucial for fine-tuning gene expression.
  • Monoamine concentrations dictate modification: The paper strongly suggests that the local concentration of available monoamine donors directly influences which modification TGM2 installs on histones. This highlights a direct link between the extracellular chemical environment and epigenetic regulation.
  • Discovery of H3Q5 histaminylation: The identification of H3Q5 histaminylation (H3Q5his) as a novel histone modification is a significant finding, particularly its dynamic diurnal expression in the brain.
  • H3Q5his as a regulator of neural rhythmicity: The research demonstrates that H3Q5his is not just present but actively contributes to neural rhythmicity, influencing gene expression patterns and locomotor behavior.
  • Antagonistic role of H3Q5his in H3K4 methylation: H3Q5his appears to antagonize the activity of the MLL1 complex, which is responsible for H3K4 methylation, suggesting a complex interplay between different histone modifications.

Key Results

  • TGM2 was shown to catalyze the addition of serotonin (H3Q5ser), dopamine (H3Q5dop), and histamine (H3Q5his) to histone H3 at glutamine 5.
  • TGM2 was also demonstrated to remove these monoamine adducts, converting them back to glutamate (H3Q5E), acting as an "eraser."
  • In the presence of different monoamine donors, TGM2 could "re-write" existing monoaminylations into new ones.
  • H3Q5his was found to be rhythmically expressed in the tuberomammillary nucleus (TMN) of the mouse brain, correlating with the expression of genes involved in circadian rhythmicity.
  • Perturbing H3Q5his dynamics in the TMN led to abnormal locomotor activity patterns, indicating a role in behavioral rhythmicity.
  • H3Q5his was shown to inhibit the binding of the MLL1 complex to H3 tails, thereby attenuating H3K4 methylation.

Limitations and Future Work

  • In vitro vs. In vivo complexity: While in vitro studies provide mechanistic insights, the full complexity of TGM2's regulation and its interplay with other factors in vivo requires further investigation.
  • Cell-type specificity: The current study focuses on specific cell types and brain regions. Future work could explore how TGM2's "re-writing" capabilities vary across different neural cell types and their specific roles in mediating transcription.
  • Broader implications of TGM2's "re-writing": The paper suggests that TGM2's ability to switch between monoaminylation states is a critical mechanism for maintaining cellular homeostasis during fluctuating intracellular monoamine levels. Further research could elucidate the broader physiological and pathological implications of this dynamic regulation.
  • Therapeutic potential: Understanding how TGM2 and H3Q5his influence neural rhythmicity could open avenues for therapeutic interventions targeting sleep-wake disorders or other rhythm-related neurological conditions.

Summary updated

Abstract

ABSTRACT Histone H3 monoaminylations at glutamine(Q) 5 represent an important family of epigenetic markers in neurons that play critical roles in the mediation of permissive gene expression (1, 2). We previously demonstrated that H3Q5 serotonylation(ser) and dopaminylation(dop) are catalyzed by the Transglutaminase 2 (TGM2) enzyme and alter both local and global chromatin states (3, 4). Here, we found that TGM2 additionally functions as an “eraser” of H3 monoaminylations that is capable of “re-writing” these epigenetic marks in cells, including a new class of this modification, H3Q5 histaminylation(his), which displays dynamic diurnal expression in brain and contributes to neural rhythmicity. We found that H3Q5his inhibits binding of the MLL1 complex to the H3 N-terminus and attenuates its methyltransferase activity on H3 lysine(K) 4. We determined that H3Q5 monoaminylation dynamics are dictated by local monoamine concentrations, which are utilized by TGM2. Taken together, we present here a novel mechanism through which a single chromatin regulatory enzyme is capable of sensing chemical microenvironments to affect the epigenetic states of cells. One sentence summary A single enzyme, TGM2, bidirectionally controls H3 monoaminylation dynamics, which, in turn, facilitate neural rhythmicity.
BibTeX
@misc{zheng2022histone,
  author = {Qingfei Zheng and Ryan M. Bastle and Shuai Zhao and Lingchun Kong and Lauren E. Vostal and Aarthi Ramakrishnan and Li Shen and Sasha L. Fulton and Haifeng Wang and Baichao Zhang and Akhil Upad and Lauren Dierdorff and Robert E. Thompson and Henrik Molina and Stephanie Stransky and Simone Sidoli and Tom W. Muir and Haitao Li and Yael David and Ian Maze},
  title = {{Histone monoaminylation dynamics are regulated by a single enzyme and promote neural rhythmicity}},
  year = {2022},
  doi = {10.1101/2022.12.06.519310},
  howpublished = {bioRxiv},
}

Loading related content...

Figure